Research News for 2010
-
Melatonin Cream May Reduce Risk of Radiation Therapy Skin Side Effects
A small, early study found that a topical melatonin cream applied to the skin before radiation therapy reduced the risk of skin side effects.
-
Arimidex-Testosterone Combo May Ease Menopausal Symptoms
An experimental testosterone/Arimidex pellet implanted under the skin every 90 days may help ease menopausal symptoms in breast cancer survivors.
-
Arimidex Still Better Than Tamoxifen After Surgery to Reduce Recurrence Risk
After 10 years of follow-up, research shows that 5 years of Arimidex is better at reducing the risk of hormone-receptor-positive breast cancer recurrence than 5 years of tamoxifen.
-
Experimental Gamma Imaging Better Than Ultrasound for Suspicious Areas
Breast-specific gamma imaging seems to be better than ultrasound at finding breast cancer when a screening mammogram shows a suspicious area.
-
“Chemobrain” Isn’t Limited to Women Who Get Chemo for Breast Cancer
Thinking problems affect people diagnosed with a variety of cancers, no matter what type of treatment they get; in other words, chemobrain isn't limited to only women who get chemotherapy for breast cancer.
-
Menopausal Symptoms, Chemo Side Effects Linked to Lower Quality of Life
Lower quality of life during and after breast cancer treatment seems to be closely linked to two factors: menopausal symptoms and chemotherapy side effects.
-
Herceptin-Avastin-Taxotere Combo Can Help Treat Metastatic HER2-Positive Breast Cancer
A small, very early study found that about 78% of women diagnosed with metastatic, HER2-positive breast cancer got some benefit from a combination of Herceptin, Avastin, and Taxotere as a first treatment.
-
Aromatase Inhibitor Before Surgery May Make Lumpectomy an Option
Many women diagnosed with hormone-receptor-positive, early-stage breast cancer for whom mastectomy was recommended may be candidates for lumpectomy after taking an aromatase inhibitor.
-
Breast Cancer Survival Triples in Last 60 Years
During the past 60 years, the average number of women who survived for 10 years after being diagnosed with breast cancer and treated at the University of Texas MD Anderson Cancer Center tripled.
-
Starting Mammograms at Age 40 Saves Lives
A very large Swedish study found that women who started getting screening mammograms at age 40 instead of 50 were 26% less likely to die from breast cancer.
